Drug Target Review

JUNE 8, 2023

In this article, Dr Andy Souers, distinguished research fellow at AbbVie in Oncology Discovery Research, discusses a 20-year quest for AbbVie researchers to find an enhanced therapeutic chemotherapy-free approach for blood cancer, that restores the body’s ability to fight cancer.

Treatment 105

Treatment Organic Chemistry Research Disease 105

Drug Target Review

SEPTEMBER 28, 2023

I started my journey in chemistry – first as an undergraduate and then in my PhD programme at the University of Houston, where I focused on organic chemistry and nucleic acids chemistry. Could you share an example of a specific project or research that you have worked on and the impact it has had in your field?

DNA 116

DNA Organic Chemistry Science Virus 116

Drug Target Review

JULY 4, 2023

In this article, Petra Dieterich, Ian Glassford, and Jeff Mocny, Scientific Leaders at Abzena discuss real-world data that is challenging traditional scientific thinking on the ADC therapeutic window. Petra holds a D.Phil in synthetic organic chemistry and am MBA from Imperial College London.

Small Molecule 145

Small Molecule Drugs Clinical Pharmacology Trials 145

The Pharma Data

OCTOBER 23, 2020

Elmaleh’s research has yielded compounds with potential in oncology, heart disease and neurodegenerative conditions, BOSTON, MA, October 23, 2020 /24-7PressRelease/ — Marquis Who’s Who, the world’s premier publisher of biographical profiles, is proud to honor David.

Organic Chemistry 52

Organic Chemistry Clinical Trials Science Pharmaceuticals 52

The Pharma Data

NOVEMBER 11, 2020

Dr. McChesney is the founder and chief executive officer of Cloaked Therapeutics and Arbor Therapeutics, through which he has drawn on more than five decades of research in natural products chemistry to identify and develop novel cancer treatments. a consulting and research firm where he acted as the principal until 2017.

Organic Chemistry 52

Organic Chemistry Science Pharmaceuticals Pharmacy 52

Agency IQ

JULY 7, 2023

These carbon-fluorine bonds are some of the strongest in organic chemistry, meaning that most PFAS readily persist in the environment. The Senate’s Environment and Public Works Committee (EPW) also recently introduced a bill to accelerate PFAS research in the country and set enforceable deadlines for the EPA’s PFAS NPDWR.

Laboratories 40

Laboratories Regulations Organic Chemistry Research Laboratories 40

Drug Hunter

AUGUST 21, 2023

This article will discuss various molecular design strategies for reducing BBB efflux and increasing passive permeability. The use of in silico and in vitro assays alleviates ethical concerns on extensive animal research in keeping with the three Rs (Replacement, Reduction, Refinement).

Drugs 206

Drugs Disease Targeted Protein Degradation Screening Hits 206